Barely Significant
← all excerpts

Empagliflozin Leads to Faster Improvement in Arterial Stiffness Compared to Dapagliflozin: A Double-Blind Clinical.

Life (Basel) · 2025 · PMC12113407 · PMID 40430228

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
In our study, empagliflozin has a significantly greater effect in reducing cf-PWV compared to dapagliflozin, with a highly significant difference ( p < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.